Ottawa shunning B.C. lead on AIDS

B.C.’s successful policies for fighting HIV/AIDs are increasingly being adopted by other countries, but not by the Canadian government, says the director for the B.C. Centre for Excellence in HIV/AIDS.

Dr. Julio Montaner credits “unwavering support” by the B.C. Ministry of Health in seeing the provincial infection rate drop far below the national average. But he said that even as a special AIDS adviser to the United Nations, he can’t get Ottawa to adopt the strategies that made it happen.

A federal spokesman responded that the government supports the principles of B.C.’s plan, but that health care is primarily a provincial responsibility.

The UNAIDS 90-90-90 treatment targets – referring to the percentage of HIV cases diagnosed, treated and achieving no virus in the bloodstream – are aimed at rendering HIV/AIDS “a sporadic disease by 2030,” according to the centre.

They are based on B.C.’s Treatment as Prevention® policy, which seeks to ensure 90 per cent of HIV cases are diagnosed by 2020; 90 per cent of patients have access to free, high-quality treatment; and at least 90 per cent of patients are virally suppressed by 2020.

Panama adopted 90-90-90 on June 29. China, France, Brazil, Spain, Argentina, Swaziland and U.S. have already adopted Treatment as Prevention®, the centre notes, and San Francisco, New York City and Washington, D.C., have also signed on.

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below